ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $289,012 | -86.0% | 15,845 | -84.1% | 0.00% | -100.0% |
| Q4 2022 | $2,061,465 | -7.0% | 99,684 | +17.6% | 0.00% | -33.3% |
| Q3 2022 | $2,217,000 | +23.9% | 84,760 | +20.0% | 0.00% | +50.0% |
| Q2 2022 | $1,790,000 | +9.3% | 70,650 | +36.2% | 0.00% | 0.0% |
| Q1 2022 | $1,638,000 | -74.5% | 51,889 | -67.3% | 0.00% | -66.7% |
| Q4 2021 | $6,424,000 | +824.3% | 158,727 | +696.9% | 0.01% | +500.0% |
| Q3 2021 | $695,000 | -75.8% | 19,919 | -81.0% | 0.00% | -66.7% |
| Q2 2021 | $2,872,000 | -27.5% | 104,578 | -25.9% | 0.00% | -40.0% |
| Q1 2021 | $3,962,000 | +211.7% | 141,097 | +188.2% | 0.01% | +150.0% |
| Q4 2020 | $1,271,000 | – | 48,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |